Venclexta
Venclexta (Venetoclax) Mechanism of Action Potent, selective inhibitor of BCL‑2 – binds the BH3 domain of BCL‑2, displacing pro‑apoptotic proteins (BAX, BAK) and triggering mitochondrial outer‑membrane permeabilization. Overcomes anti‑apoptotic signaling in malignant B‑cell clones and AML blasts, restoring apoptotic priming that is otherwise suppressed in disease. Synergistic when combined with hypomethylating agents (decitabine) or with … Read more